BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 30962630)

  • 21. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
    Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P
    Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
    Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
    Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
    Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
    J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma.
    Hara T; Chanoch-Myers R; Mathewson ND; Myskiw C; Atta L; Bussema L; Eichhorn SW; Greenwald AC; Kinker GS; Rodman C; Gonzalez Castro LN; Wakimoto H; Rozenblatt-Rosen O; Zhuang X; Fan J; Hunter T; Verma IM; Wucherpfennig KW; Regev A; Suvà ML; Tirosh I
    Cancer Cell; 2021 Jun; 39(6):779-792.e11. PubMed ID: 34087162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of AHR and HIF-1α in Glioblastoma Metabolism.
    Gabriely G; Wheeler MA; Takenaka MC; Quintana FJ
    Trends Endocrinol Metab; 2017 Jun; 28(6):428-436. PubMed ID: 28318896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR4 expression and functionality are downregulated in glioblastoma cells and in tumor-associated macrophages: A new mechanism of immune evasion?
    da Cruz LLP; de Souza PO; Dal Prá M; Falchetti M; de Abreu AM; Azambuja JH; Bertoni APS; Paz AHR; Araújo AB; Visioli F; Fazolo T; da Silva GG; Worm PV; Wink MR; Zanotto-Filho A; Braganhol E
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166155. PubMed ID: 33932524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aryl Hydrocarbon Receptor Signaling Controls CD155 Expression on Macrophages and Mediates Tumor Immunosuppression.
    McKay ZP; Brown MC; Gromeier M
    J Immunol; 2021 Mar; 206(6):1385-1394. PubMed ID: 33504618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
    Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression.
    Chalmin F; Mignot G; Bruchard M; Chevriaux A; Végran F; Hichami A; Ladoire S; Derangère V; Vincent J; Masson D; Robson SC; Eberl G; Pallandre JR; Borg C; Ryffel B; Apetoh L; Rébé C; Ghiringhelli F
    Immunity; 2012 Mar; 36(3):362-73. PubMed ID: 22406269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
    Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
    Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury.
    Bönner F; Borg N; Burghoff S; Schrader J
    PLoS One; 2012; 7(4):e34730. PubMed ID: 22514659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
    Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
    Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Assay to Study Tumor-macrophage Interaction.
    An Z; Weiss WA
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31424440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.
    Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV
    J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn's Disease.
    Robles RJ; Mukherjee S; Vuerich M; Xie A; Harshe R; Cowan PJ; Csizmadia E; Wu Y; Moss AC; Chen R; Robson SC; Longhi MS
    J Crohns Colitis; 2020 Jul; 14(6):818-830. PubMed ID: 31693091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.
    Perrot I; Michaud HA; Giraudon-Paoli M; Augier S; Docquier A; Gros L; Courtois R; Déjou C; Jecko D; Becquart O; Rispaud-Blanc H; Gauthier L; Rossi B; Chanteux S; Gourdin N; Amigues B; Roussel A; Bensussan A; Eliaou JF; Bastid J; Romagné F; Morel Y; Narni-Mancinelli E; Vivier E; Paturel C; Bonnefoy N
    Cell Rep; 2019 May; 27(8):2411-2425.e9. PubMed ID: 31116985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia.
    Pulte D; Furman RR; Broekman MJ; Drosopoulos JH; Ballard HS; Olson KE; Kizer JR; Marcus AJ
    Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):367-72. PubMed ID: 21816376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-kynurenine/aryl hydrocarbon receptor pathway mediates brain damage after experimental stroke.
    Cuartero MI; Ballesteros I; de la Parra J; Harkin AL; Abautret-Daly A; Sherwin E; Fernández-Salguero P; Corbí AL; Lizasoain I; Moro MA
    Circulation; 2014 Dec; 130(23):2040-51. PubMed ID: 25359166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
    Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
    Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses.
    Kimura A; Naka T; Nakahama T; Chinen I; Masuda K; Nohara K; Fujii-Kuriyama Y; Kishimoto T
    J Exp Med; 2009 Aug; 206(9):2027-35. PubMed ID: 19703987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.